Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Cancer Res ; 58(10): 2253-9, 1998 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-9605774

RESUMO

The activation status of the ras pathway was studied in eight ovarian tumor cell lines. Three biochemical parameters indicative of ras activation were tested: (a) the ratio of the ras-GTP:ras-GDP complex; (b) the activity of mitogen-activated protein kinases p42/p44; and (c) ets-2 phosphorylation at position threonine 72, a mitogen-activated protein kinase phosphorylation site in vivo. Four of the ovarian tumor cell lines had an activated ras pathway by these three parameters, whereas only one of these contained a mutated ras gene. In addition, ras/ets-2 responsive genes such as the urokinase plasminogen activator (uPA) were activated in these four cell lines. Transient transfection assays indicated that the compound ets-AP1 oncogene responsive enhancer present in the uPA gene was the target of ras signaling in ovarian tumor cells and that the combination of activated ras and ets-2 could superactivate the uPA enhancer element. Coexpression of the dominant-negative ras-Asn17 cDNA gene abrogated activity of this uPA element in ovarian tumor cells. These data indicate that ets-2 is a nuclear target of ras action in ovarian tumor cell lines and that ras signaling pathways may be activated in ovarian cancer by mechanisms independent of direct genetic damage to ras genes.


Assuntos
Proteínas Quinases Dependentes de Cálcio-Calmodulina/metabolismo , Carcinoma/metabolismo , Proteínas de Ligação a DNA , Genes ras/efeitos dos fármacos , Neoplasias Ovarianas/metabolismo , Proteínas Proto-Oncogênicas/metabolismo , Proteínas Repressoras , Transativadores/metabolismo , Fatores de Transcrição , Antineoplásicos/farmacologia , Carcinoma/enzimologia , Carcinoma/genética , Ativação Enzimática , Feminino , Regulação da Expressão Gênica , Genes ras/fisiologia , Genisteína/farmacologia , Guanosina Trifosfato/metabolismo , Humanos , Neoplasias Ovarianas/enzimologia , Neoplasias Ovarianas/genética , Fosforilação , Proteína Proto-Oncogênica c-ets-2 , Células Tumorais Cultivadas/efeitos dos fármacos , Ativador de Plasminogênio Tipo Uroquinase/genética , Ativador de Plasminogênio Tipo Uroquinase/metabolismo
2.
Appl Environ Microbiol ; 34(4): 382-5, 1977 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-335971

RESUMO

Bacterial lipopolysaccharides are recognized as the major cause of pyrogenic reactions from parenteral solutions. Molecular filtration was used to remove these pyrogenic molecules (endotoxins) from contaminated parenteral solutions. Because bacterial lipopolysaccharides can exist in different states of aggregation, depending on the composition of the solution they are suspended in, the full range of possible states of aggregation was examined by using filters with a wide range of pore sizes. Filters of different pore sizes retained endotoxin lipopolysaccharide presumed to be in the vesicle form, the micelle form, or the detergent-solubilized form in aqueous solutions. Endotoxins (pyrogens) were successfully removed from artificially contaminated solutions of concentrated antibiotics by using filters of 10,000-nominal-molecular-weight limit.


Assuntos
Endotoxinas/isolamento & purificação , Escherichia coli/análise , Lipopolissacarídeos/isolamento & purificação , Filtros Microporos , Polissacarídeos Bacterianos/isolamento & purificação , Pirogênios/isolamento & purificação , Soluções/análise , Carbenicilina/análise , Cefalotina/análise , Contaminação de Medicamentos , Teste do Limulus , Cloreto de Sódio/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA